First Bankers Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,565
Closed -$477K 119
2021
Q4
$477K Sell
6,565
-2,587
-28% -$178K 0.21% 98
2021
Q3
$639K Sell
9,152
-6,276
-41% -$441K 0.32% 82
2021
Q2
$1.06M Sell
15,428
-10,329
-40% -$690K 0.52% 65
2021
Q1
$1.67M Buy
25,757
+2,989
+13% +$193K 0.7% 56
2020
Q4
$1.33M Sell
22,768
-5,346
-19% -$323K 0.51% 60
2020
Q3
$1.78M Sell
28,114
-90
-0.3% -$6.24K 0.76% 55
2020
Q2
$2.17M Sell
28,204
-1,087
-4% -$83.3K 0.97% 38
2020
Q1
$2.19M Buy
29,291
+1,867
+7% +$129K 1.13% 32
2019
Q4
$1.78M Buy
27,424
+4,317
+19% +$281K 0.75% 48
2019
Q3
$1.47M Buy
23,107
+4,734
+26% +$309K 0.66% 52
2019
Q2
$1.24M Buy
18,373
+2,774
+18% +$182K 0.57% 60
2019
Q1
$1.01M Sell
15,599
-11,725
-43% -$779K 0.48% 67
2018
Q4
$1.71M Buy
27,324
+16,990
+164% +$1.19M 0.44% 66
2018
Q3
$798K Buy
10,334
+3,805
+58% +$287K 0.38% 72
2018
Q2
$463K Buy
6,529
+1,734
+36% +$122K 0.24% 95
2018
Q1
$361K Buy
+4,795
New +$381K 0.19% 96

Other funds holding GILD

First Bankers Trust's GILD Position: Q1 2022 in Review

First Bankers Trust sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 6,565 shares — an estimated $477K sold.

First Bankers Trust first reported a position in GILD in Q1 2018 and held it in 16 quarters. The position peaked at $2.19M in Q1 2020. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • First Bankers Trust reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • First Bankers Trust sold 6,565 Gilead Sciences shares in Q1 2022, an estimated $477K.
  • First Bankers Trust first reported a position in Gilead Sciences in Q1 2018 and held it in 16 quarters.
  • First Bankers Trust's Gilead Sciences position peaked at $2.19M in Q1 2020.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on First Bankers Trust's 13F filing for Q1 2022, filed 14 Apr 2022.